Chongqing University Cancer Hospital
Clinical trials sponsored by Chongqing University Cancer Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cocktail of drugs shows promise for Tough-to-Treat throat cancer Results expected Feb 2027 (estimated)
- Could storing your own stem cells shield bone marrow during cancer treatment? Results expected Apr 2027 (estimated)
- Own stem cells may shield bone marrow during ovarian cancer chemo Results expected May 2027 (estimated)
-
New combo therapy tailors radiation for advanced nasopharyngeal cancer
Disease control OngoingThis phase II trial tests a personalized treatment for metastatic nasopharyngeal carcinoma. Patients first receive tislelizumab (immunotherapy) plus chemotherapy. Those who respond well may avoid or reduce radiotherapy, while others get targeted radiation. The study aims to see i…
Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a simple pill keep nasopharyngeal cancer away?
Disease control OngoingThis Phase III trial tests whether adding a low-dose chemotherapy pill (capecitabine) after standard chemoradiation helps prevent cancer from returning in people with high-risk nasopharyngeal cancer. About 252 participants with stage T1-2N1M0 disease and certain high-risk feature…
Phase 3 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC